Newly discovered compounds could revitalize older drugs, making them effective against resistant superbugs

With more than 23,000 people dying annually in the United States from bacterial infections that have evolved to resist antibiotics, researchers are taking a novel approach to address the looming public health crisis: They’re helping develop new drugs to make old drugs work better. “As our antibiotics work less and less, we risk essentially going back to a period 200 years ago when even a minor infection could mean death.” Read article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.